Oral minocycline in the treatment of vitiligo - A preliminary study

Dermatologic Therapy

Volumn 23, Issue 3, 2010, Pages 305-307

  Parsad, Davinder ^a   Kanwar, Amrinderjit ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Minocycline; Treatment; Vilitigo

Indexed keywords

MINOCYCLINE; ANTIINFLAMMATORY AGENT;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; DEPIGMENTATION; DISEASE ACTIVITY; DRUG EFFICACY; FEMALE; HUMAN; MALE; OUTCOME ASSESSMENT; TREATMENT DURATION; VITILIGO; CLINICAL TRIAL; MIDDLE AGED; ORAL DRUG ADMINISTRATION; YOUNG ADULT;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MINOCYCLINE; VITILIGO; YOUNG ADULT;

EID: 77952724670     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2010.01328.x     Document Type: Article

References (11)

1. Lerner A. On the etiology of vitiligo and grey hair. Am J Med 1971 : 51 : 141 147.
2. Howitz J, Brodthage H, Schwartz M, Thomsen K. Prevalence of vitiligo. Arch Dermatol 1997 : 113 : 47 52.
3. Passi S, Grandinetti M, Maggio F, et al. Epidermal oxidative stress in vitiligo. Pigment Cell Res 1998 : 11 : 81 85.
4. Pasricha JS, Khaitan BK. Oral mini pulse therapy with betamethasone in vitiligo patients having extensive or fast spreading disease. Int J Dermatol 1993 : 32 : 753 757.
5. Parsad D, Pandhi R, Juneja A. Effectiveness of oral Ginkgo biloba in treating limited, slowly spreading vitiligo. Clin Exp Dermatol 2003 : 28 : 285 287.
6. 2-induced cell death via JNK and p38 MAPK pathways. Int J Mol Med 2008 : 22 : 9 16.
7. Nieman GF, Zerler BR. A role for the anti-inflammatory properties of tetracyclines in the prevention of acute lung injury. Curr Med Chem 2001 : 8 : 317 325.
8. Cheung P-Y, Sawicki G, Wozniak M, Wang W, Radomski MW, Schulz R. Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart. Circulation 2000 : 101 : 1833 1839.
9. Power C, Henry S, Del Bigio MR, et al. Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases. Ann Neurol 2003 : 53 : 731 742.
10. Zhu S, Stavrovskaya IG, Drozda M, et al. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 2002 : 417 : 74 78.
11. Kraus RL, Pasiweczny R, Lariosa-Willingham K, Turner MS, Jiang A, Trauger JW. Antioxidant properties of minocycline. Neuroprotection in an oxidative stress assay and direct radical-scavenging activity. J Neurochem 2005 : 94 : 819 827.